Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Issues New Medical Device GMP Standards, Set To Take Effect On New Year's Day Of 2011

This article was originally published in PharmAsia News

Executive Summary

BEIJING - China's State FDA has issued a wide-ranging compilation of good manufacturing practice standards for medical devices, set to become effective one year from now, that for the first time will cover all manufacturers across the country, according to lawyers who closely monitor the sector

You may also be interested in...



Insider Analysis From Asia Pacific Bio Intelligence LLC On China State FDA’s Medical Device Regulations

For China’s State FDA, 2011 was a banner year, with regulations released on good manufacturing practices for both drugs and devices. Multinational companies should take notice and be sure their operations are in compliance.

China One Step Closer To Global Standards For Drug Quality With Rollout Of New GMP Guidelines

SHANGHAI - China's State FDA recently issued a note to provincial FDA offices to require pharma companies and active pharmaceutical ingredient producers to file a Common Technical Document when they submit manufacturing applications as an effort to improve drug quality and research and development work in China

China One Step Closer To Global Standards For Drug Quality With Rollout Of New GMP Guidelines

SHANGHAI - China's State FDA recently issued a note to provincial FDA offices to require pharma companies and active pharmaceutical ingredient producers to file a Common Technical Document when they submit manufacturing applications as an effort to improve drug quality and research and development work in China

Related Content

UsernamePublicRestriction

Register

PL220371

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel